What is the most common T cell type involved in inflammatory bowel disease?

What is the most common T cell type involved in inflammatory bowel disease?

• A. CD4+
• B. CD8+
• C. CD5+
• D. CD3+

Answer: (A)

In inflammatory bowel disease, the immune response that drives the inflammation is largely coordinated by helper T cells. The most common T cell type involved is the CD4+ T lymphocyte. These cells act as the central regulators, differentiating into Th1 and Th17 subsets in gut tissue and secreting cytokines such as interferon-gamma and IL-17 that recruit and activate other immune cells. This cytokine milieu sustains chronic mucosal inflammation, making CD4+ T cells the predominant infiltrating T cell population seen in inflamed gut tissue. Cytotoxic CD8+ T cells do contribute to the immune milieu, but they are not the primary drivers of the inflammatory cascade in most IBD lesions. Markers like CD3+ identify all T cells, and CD5+ is a general T cell marker as well, so they don’t pinpoint the major effector population. The key takeaway is that CD4+ helper T cells are the main players orchestrating the inflammatory process in IBD.

In inflammatory bowel disease, the immune response that drives the inflammation is largely coordinated by helper T cells. The most common T cell type involved is the CD4+ T lymphocyte. These cells act as the central regulators, differentiating into Th1 and Th17 subsets in gut tissue and secreting cytokines such as interferon-gamma and IL-17 that recruit and activate other immune cells. This cytokine milieu sustains chronic mucosal inflammation, making CD4+ T cells the predominant infiltrating T cell population seen in inflamed gut tissue.

Cytotoxic CD8+ T cells do contribute to the immune milieu, but they are not the primary drivers of the inflammatory cascade in most IBD lesions. Markers like CD3+ identify all T cells, and CD5+ is a general T cell marker as well, so they don’t pinpoint the major effector population. The key takeaway is that CD4+ helper T cells are the main players orchestrating the inflammatory process in IBD.